IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $591,319 | +100.4% | 72,733 | +12.1% | 0.11% | +81.0% |
| Q3 2023 | $295,127 | -25.6% | 64,863 | +15.1% | 0.06% | -20.3% |
| Q2 2023 | $396,641 | +26.9% | 56,341 | +10.1% | 0.08% | -12.2% |
| Q1 2023 | $312,643 | +33.6% | 51,169 | +39.7% | 0.09% | -60.4% |
| Q4 2022 | $234,008 | -34.6% | 36,621 | -2.1% | 0.23% | -31.0% |
| Q3 2022 | $358,000 | -17.7% | 37,401 | -5.2% | 0.33% | -0.6% |
| Q2 2022 | $435,000 | -38.0% | 39,434 | -6.5% | 0.33% | 0.0% |
| Q1 2022 | $702,000 | -28.7% | 42,183 | -18.2% | 0.33% | -7.5% |
| Q4 2021 | $984,000 | – | 51,540 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |